C3 glomerulopathy is a relatively new clinical entity that represents a challenge both to
diagnose and to treat. As new therapeutic agents that act as complement inhibitors become …

C3 glomerulopathy is an umbrella term, which includes several rare forms of
glomerulonephritis (GN) with underlying defects in the alternate complement cascade. A …

Recent advances in our understanding of the disease pathology of membranoproliferative
glomerulonephritis has resulted in its re-classification as complement C3 glomerulopathy …

Abstract Background Complement 3 glomerulopathy (C3GN) is a newly proposed
subcategory of glomerular disease with features including membranoproliferative …

C3 glomerulopathy (C3G) is a newly defined clinical entity comprising glomerular lesions
with predominant C3 staining. Under this definition are now included membranoproliferative …

ABSTRACT C3 glomerulopathy is a rare renal disease that has been distinguished as a
renal disease for about 10 years. It is caused by an excessive activation of the alternative …

Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity secondary to dysregulation of
the alternative complement pathway in plasma and the glomerular microenvironment. The …

Whereas early classifications of membranoproliferative glomerulonephritis (MPGN) were
based on morphologic features, the modern approach is directed at immunofluorescence …

Abstract C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily
affects young adults. Renal outcomes remain poor in the absence of specific treatment. C3G …

Membranoproliferative glomerulonephritis (MPGN) is a rare chronic kidney disease
associated with complement activation. Recent immunofluorescence-based classification …